DEMA Stock Overview
Operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 35.54 |
| 52 Week High | DKK 49.76 |
| 52 Week Low | DKK 33.40 |
| Beta | 1.02 |
| 11 Month Change | -1.50% |
| 3 Month Change | -3.48% |
| 1 Year Change | -3.76% |
| 33 Year Change | -22.60% |
| 5 Year Change | n/a |
| Change since IPO | 40.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEMA | AT Medical Equipment | AT Market | |
|---|---|---|---|
| 7D | 1.2% | -2.4% | 0.9% |
| 1Y | -3.8% | 13.2% | 1.5% |
Return vs Industry: DEMA underperformed the Austrian Medical Equipment industry which returned 12.9% over the past year.
Return vs Market: DEMA underperformed the Austrian Market which returned 1.5% over the past year.
Price Volatility
| DEMA volatility | |
|---|---|
| DEMA Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.3% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: DEMA has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: DEMA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 21,501 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
| DEMA fundamental statistics | |
|---|---|
| Market cap | €7.73b |
| Earnings (TTM) | €339.84m |
| Revenue (TTM) | €3.06b |
22.7x
P/E Ratio2.5x
P/S RatioIs DEMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMA income statement (TTM) | |
|---|---|
| Revenue | DKK 22.84b |
| Cost of Revenue | DKK 5.80b |
| Gross Profit | DKK 17.04b |
| Other Expenses | DKK 14.50b |
| Earnings | DKK 2.54b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.64 |
| Gross Margin | 74.61% |
| Net Profit Margin | 11.10% |
| Debt/Equity Ratio | 137.5% |
How did DEMA perform over the long term?
See historical performance and comparison